“In the wake of Monday's promising announcement by BioNTech and Pfizer on the prospects for their vaccine, I'm very happy to announce today's agreement ... to purchase 300 million doses,” European Commission President Ursula von der Leyen announced in a statement on Wednesday.
According to BioNTech, the contract will guarantee the supply of 200 million doses, with an option to procure an additional 100 million doses. The pharmaceutical company says it expects deliveries to begin by the end of 2020, pending approval of the vaccine by the European Medical Agency.
“As a company founded in the heart of Europe, we are looking forward to supplying millions of people upon regulatory approval,” BioNTech CEO Ugur Sahin said in a company statement Wednesday.
“Our aim is to develop a safe and effective vaccine to contribute to bringing this pandemic to an end. Only through joint efforts will we be able to do so,” Sahin added (Source: CNN).
Iranian High Tech Products Are to Be Exported to EAEU
